Cloning of anti-HBsAg single-chain variable fragments from hybridoma cells for one-step ELISA

Hepatitis B virus (HBV) infection is a worldwide health problem. More than 400 million people are chronic HBV carriers in the world. Infected individuals are at a high risk of developing liver cirrhosis and hepatocellular carcinoma as the main consequences of HBV. The discoveries of fast diagnostic...

Full description

Bibliographic Details
Main Authors: Berrin Erdag, Koray Bertan Balcioglu, Aylin Ozdemir Bahadir, Duygu Hinc, Ozlem Ibrahimoglu, Aydin Bahar, Aynur Basalp, Fatima Yucel
Format: Article
Language:English
Published: Taylor & Francis Group 2017-09-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Online Access:http://dx.doi.org/10.1080/13102818.2017.1348256